Bioxyne
(ASX) BXN
Bioxyne Financials at a Glance
Market Cap
$149.78M
Revenue (TTM)
$66.36M
Net Income (TTM)
$11.20M
EPS (TTM)
$0.00
P/E Ratio
16.10
Dividend
$0.00
Beta (Volatility)
0.36 (Low)
Dividend
$0.00
Beta (Volatility)
0.36 (Low)
Price
$0.06
Volume
695,875
Open
$0.07
Price
$0.06
Volume
695,875
Open
$0.07
Previous Close
$0.07
Daily Range
$0.06 - $0.07
52-Week Range
$0.02 - $0.07
Dividend
$0.00
Beta (Volatility)
0.36 (Low)
Price
$0.06
Volume
695,875
Open
$0.07
Previous Close
$0.07
Daily Range
$0.06 - $0.07
52-Week Range
$0.02 - $0.07
BXN News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bioxyne
Industry
Life Sciences Tools and Services
Sector
Health CareCEO
Sam Watson
Website
www.bioxyne.comHeadquarters
Sydney, NSW 2000, AU
BXN Financials
Key Financial Metrics (TTM)
Gross Margin
33%
Operating Margin
19%
Net Income Margin
18%
Return on Equity
65%
Return on Capital
38%
Return on Assets
26%
Earnings Yield
6.21%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$149.78M
Shares Outstanding
2.27B
Volume
695.88K
Short Interest
0.00%
Avg. Volume
3.73M
Financials (TTM)
Gross Profit
$10.45M
Operating Income
$5.56M
EBITDA
$5.34M
Operating Cash Flow
$6.28M
Capital Expenditure
$2.41M
Free Cash Flow
$3.86M
Cash & ST Invst.
$7.67M
Total Debt
$1.53M
Bioxyne Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$31.31M
+565.8%
Gross Profit
$12.17M
+943.7%
Gross Margin
38.88%
N/A
Market Cap
$149.78M
N/A
Market Cap/Employee
$9.36M
N/A
Employees
16
N/A
Net Income
$7.34M
+159.8%
EBITDA
$8.22M
+166.4%
Quarterly Fundamentals
Net Cash
$173.90K
-88.6%
Accounts Receivable
$6.01M
+368.3%
Inventory
$11.73M
+650.9%
Long Term Debt
$6.22M
N/A
Short Term Debt
$1.21M
N/A
Return on Assets
25.89%
N/A
Return on Invested Capital
37.75%
N/A
Free Cash Flow
$2.27M
-2.0%
Operating Cash Flow
$1.29M
+41.5%